Julie Avolio

Toronto, ON M5G0A4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

PangyPlot: multi-scale interactive visualization of pangenome variation graphs.

PangyPlot: multi-scale interactive visualization of pangenome variation graphs.

Journal: Bioinformatics (Oxford, England)

Published: April 24, 2026

Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis.

Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 16, 2025

Nasal cells as a bronchial cell surrogate for pre-clinical assessment of drug response in cystic fibrosis.

Nasal cells as a bronchial cell surrogate for pre-clinical assessment of drug response in cystic fibrosis.

Journal: Frontiers in pharmacology

Published: June 20, 2025

Distinct regulatory elements of SLC6A14 expression contribute to modification of cystic fibrosis phenotypes.

Distinct regulatory elements of SLC6A14 expression contribute to modification of cystic fibrosis phenotypes.

Journal: Human genetics

Published: June 16, 2025

GWAS SVatalog: a visualization tool to aid fine-mapping of GWAS loci with structural variations.

GWAS SVatalog: a visualization tool to aid fine-mapping of GWAS loci with structural variations.

Journal: Heredity

Published: January 20, 2025

Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis.

Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis.

Journal: The European respiratory journal

Published: April 16, 2024

Primary Human Nasal Epithelial Cell Culture.

Primary Human Nasal Epithelial Cell Culture.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 19, 2023

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass.

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass.

Journal: Frontiers in pharmacology

Published: February 03, 2023

Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis.

Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis.

Journal: Life science alliance

Published: November 26, 2022

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

Journal: HGG advances

Published: July 08, 2022

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Journal: NPJ genomic medicine

Published: December 30, 2021

Expression of cystic fibrosis lung disease modifier genes in human airway models.

Expression of cystic fibrosis lung disease modifier genes in human airway models.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: September 08, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026